149 search results for “titel therapy” in the Staff website
-
Model-informed Design of Antibiotic Therapy against Antimicrobial Resistance
PhD defence
-
Erica Bohnen
Faculty of Social and Behavioural Sciences
bohnen@fsw.leidenuniv.nl | 071 5273381
-
Developing new therapies to fight muscle disease
Biophysicist Alireza Mashaghi and his collaborators are taking up the fight against muscular dystrophy: genetic disorders that cause muscle weakness. They want to inhibit the clumping of proteins that results in toxic aggregates. For this, the team receives 550,000 euros from Health Holland. The team…
-
Jessy Terpstra
Faculty of Social and Behavioural Sciences
j.a.terpstra@fsw.leidenuniv.nl | 071 5272727
-
Oncode Accelerator funds preclinical development of cancer therapies
Through its Demonstrator Projects, the Dutch Oncode Accelerator consortium provides grants for preclinical cancer therapy development. The first call for these projects is open until September 2025.
-
LUMC signs international agreement on developing Advanced Therapy Medicinal Products
Skåne University Hospital, Lund University and Leiden University Medical Center will work together to expand their research, teaching and development relating to Advanced Therapy Medicinal Products. That is the essence of a Memorandum of Understanding signed at SciLifeLab near Stockholm on Wednesday…
-
Special nanoparticles for cancer therapy! Will you help?
Developing a better treatment for patients with head and neck cancer, that is what Binanox, The 2022 iGEM Leiden team, want to achieve. They hope to raise at least 10,000 euros for this cause. Support their crowdfunding campaign today.
-
A future with tailored therapy for patients with atherosclerosis
The AtheroNeth consortium received €6 million from the Dutch Heart Foundation to gain a better understanding of the differences in disease progression among patients with atherosclerosis. The ultimate goal is to enable personalised treatment.
-
patient in the Netherlands successfully treated with stem cell gene therapy
Researchers from the Leiden University Medical Center (LUMC) have successfully used stem cell gene therapy to treat a baby with the severe congenital immune disorder SCID. An important milestone: it is the first time stem cell gene therapy of Dutch origin has been administered to a patient, and also…
-
Marike KooistraFaculty of Social and Behavioural Sciences
m.j.kooistra@fsw.leidenuniv.nl | 071 5272727
-
Johanna Greeven
Faculty of Social and Behavioural Sciences
greeven@fsw.leidenuniv.nl | 071 5272727
-
‘Exposure therapy’ for bachelor students: preparing for the reality of scientific research
Already during their bachelor’s programme, students in Pharmaceutical Sciences are presented with challenging projects. One of these is the Bachelor Research Assignment (BOO in Dutch), which is often their first real experience with scientific research. This means a lot of responsibility and failures,…
-
Danielle OprelFaculty of Social and Behavioural Sciences
d.a.c.oprel@fsw.leidenuniv.nl | 071 5272727
-
Bianca BoyerFaculty of Social and Behavioural Sciences
b.e.boyer@fsw.leidenuniv.nl | 071 5272727
-
Judith Bovéej.v.m.g.bovee@lumc.nl | 071 5269111
-
Lioe-Fee de Geus-Oeil.f.de_geus-oei@lumc.nl | 071 5269111
-
Mara van OschFaculty of Social and Behavioural Sciences
m.van.osch@fsw.leidenuniv.nl | 071 5272727
-
Oana Georgiana Rus-OswaldFaculty of Social and Behavioural Sciences
o.g.rus@fsw.leidenuniv.nl | 071 5272727
-
Leiden scientists join national effort to advance nanomedicine
A Dutch consortium has received €6.7 million to accelerate the development of nanomedicines together with patients. Researchers from Leiden University play a key role in the project.
-
Webinar Transfusion Medicine and Cellular and Tissue Therapies
Study information
-
Is a cancer pill a matter of time?
A cancer pill, preferably without severe side effects, is something we’d all welcome. Is it a matter of time before such a pill is a reality? We put this question to three Leiden researchers and asked how they themselves are contributing to new cancer treatments.
-
Rick Haasr.l.m.haas@lumc.nl | 071 5269111
-
Eveline Bleikere.m.a.bleiker@lumc.nl | 071 5268033
-
John Haanenj.b.a.g.haanen@lumc.nl | 071 5263057
-
Sylvestre Bonnetbonnet@chem.leidenuniv.nl | 071 5274260
-
Jeroen Jansenj.c.jansen@lumc.nl | 071 5269111
-
Alfred Vertegaala.c.o.vertegaal@lumc.nl | 071 5269111
-
Michiel van de Sandem.a.j.van_de_sande@lumc.nl | 071 5263606
-
Jannie Keyser-Borstj.g.borst@lumc.nl |
-
Vincent Smitv.t.h.b.m.smit@lumc.nl | 071 5266622
-
Johanneke Portieljej.e.a.portielje@lumc.nl | 071 5263464
-
Monique van Leerdamm.e.van_leerdam@lumc.nl | 071 5269111
-
J Morreauj.morreau@lumc.nl | 071 5266630
-
Thorbald van Hallt.van_hall@lumc.nl | 071 5266945
-
Coen Raschc.r.n.rasch@lumc.nl |
-
Jelle Wesselingj.wesseling@lumc.nl | 071 5266622
-
Chemotherapy without side effects: Matthijs Hakkennes helps find the needle in the haystack faster
Chemotherapy, but without hair loss or extreme fatigue. It may be possible if the toxic drug only becomes active where it is ‘switched on’ by light. Matthijs Hakkennes has helped bring that idea closer to reality and obtained his PhD cum laude. ‘I received many thank-you emails from China and Bangla…
-
Health insurance
If you wish, you can take part in the collective health insurance scheme offered by Leiden University and Zorg en Zekerheid. This scheme offers a collective discount, for you and your family.
-
Leiden researchers join forces against tuberculosis
About one and a half million people worldwide die each year from tuberculosis. For thirty years, therapy with antibiotics has been the same, while it takes far too long and can lead to resistant pathogens. Leiden researchers from four institutes are now joining forces to develop more effective and efficient…
-
Gregorius Luyteng.p.m.luyten@lumc.nl | 071 5266674
-
Koos van der Hoevenj.j.m.van.der.hoeven@lumc.nl | 071 5269111
-
Maarten Vermeerm.h.vermeer@lumc.nl | 071 5261952
-
Manfred Wuhrerm.wuhrer@lumc.nl | 071 5269111
-
Henri Versteegh.h.versteeg@lumc.nl | 071 5263872
-
Hein Putterh.putter@lumc.nl | 071 5279705
-
Peter ten Dijkep.ten_dijke@lumc.nl | 071 5269270
-
Frits Koningf.koning@lumc.nl | 071 5269111
-
Psychologist for PhD candidates
If you’re working on a PhD track and are experiencing psychological issues, you can contact one of the psychologists for PhD candidates for help with problems that have arisen during the PhD process or are directly affecting this.
-
Medical Delta professor Marco van Vulpen: ‘I advocate the introduction of the share factor’
Proton therapy is a new way of treating cancer in which radiation doses are delivered more precisely. This results in less damage to surrounding tissue and fewer side effects. Professor Marco van Vulpen is medical director of HollandPTC in Delft, where the social value of this therapy is studied. Van…
-
Proof of Concept grants for four Leiden researchers
Four Leiden researchers have been awarded Proof of Concept grants by the ERC. These grants, each worth 150,000 euros, help researchers translate the findings of previous ERC projects into innovative practical applications.